Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 Oct;66(1):1–16.

Interactions of viruses with the immune system.

C A Mims
PMCID: PMC1542649  PMID: 3542314

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson J. S., Giebink G. S., Quie P. G. Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media. Infect Immun. 1982 Apr;36(1):289–296. doi: 10.1128/iai.36.1.289-296.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ahmed R., Salmi A., Butler L. D., Chiller J. M., Oldstone M. B. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med. 1984 Aug 1;160(2):521–540. doi: 10.1084/jem.160.2.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anders E. M., Scalzo A. A., White D. O. Influenza viruses are T cell-independent B cell mitogens. J Virol. 1984 Jun;50(3):960–963. doi: 10.1128/jvi.50.3.960-963.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barnaba V., Valesini G., Levrero M., Zaccari C., Van Dyke A., Falco M., Musca A., Balsano F. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients. Clin Exp Immunol. 1985 May;60(2):259–266. [PMC free article] [PubMed] [Google Scholar]
  5. Becht H. Infectious bursal disease virus. Curr Top Microbiol Immunol. 1980;90:107–121. doi: 10.1007/978-3-642-67717-5_5. [DOI] [PubMed] [Google Scholar]
  6. Borysiewicz L. K., Casali P., Rogers B., Morris S., Sissons J. G. The immunosuppressive effects of measles virus on T cell function--failure to affect IL-2 release or cytotoxic T cell activity in vitro. Clin Exp Immunol. 1985 Jan;59(1):29–36. [PMC free article] [PubMed] [Google Scholar]
  7. Brownlie J., Clarke M. C., Howard C. J. Experimental production of fatal mucosal disease in cattle. Vet Rec. 1984 Jun 2;114(22):535–536. doi: 10.1136/vr.114.22.535. [DOI] [PubMed] [Google Scholar]
  8. Bukowski J. F., Welsh R. M. Interferon enhances the susceptibility of virus-infected fibroblasts to cytotoxic T cells. J Exp Med. 1985 Jan 1;161(1):257–262. doi: 10.1084/jem.161.1.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Burstin S. J., Brandriss M. W., Schlesinger J. J. Infection of a macrophage-like cell line, P388D1 with reovirus; effects of immune ascitic fluids and monoclonal antibodies on neutralization and on enhancement of viral growth. J Immunol. 1983 Jun;130(6):2915–2919. [PubMed] [Google Scholar]
  10. CHRISTENSEN P. E., SCHMIDT H., BANG H. O., ANDERSEN V., JORDAL B., JENSEN O. An epidemic of measles in southern Greenland, 1951; measles in virgin soil. III. Measles and tuberculosis. Acta Med Scand. 1953;144(6):450–454. doi: 10.1111/j.0954-6820.1953.tb15718.x. [DOI] [PubMed] [Google Scholar]
  11. Cafruny W. A., Plagemann P. G. Immune response to lactate dehydrogenase-elevating virus: serologically specific rabbit neutralizing antibody to the virus. Infect Immun. 1982 Sep;37(3):1007–1012. doi: 10.1128/iai.37.3.1007-1012.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Carney W. P., Hirsch M. S. Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions. J Infect Dis. 1981 Jul;144(1):47–54. doi: 10.1093/infdis/144.1.47. [DOI] [PubMed] [Google Scholar]
  13. Casali P., Rice G. P., Oldstone M. B. Viruses disrupt functions of human lymphocytes. Effects of measles virus and influenza virus on lymphocyte-mediated killing and antibody production. J Exp Med. 1984 May 1;159(5):1322–1337. doi: 10.1084/jem.159.5.1322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Chong K. T., Mims C. A. Antigen-specific suppression of delayed type hypersensitivity to murine cytomegalovirus in MCMV-infected mice. J Gen Virol. 1983 Nov;64(Pt 11):2433–2439. doi: 10.1099/0022-1317-64-11-2433. [DOI] [PubMed] [Google Scholar]
  15. Chouaib S., Fradelizi D. The mechanism of inhibition of human IL 2 production. J Immunol. 1982 Dec;129(6):2463–2468. [PubMed] [Google Scholar]
  16. Cihak J., Lehmann-Grube F. Immunological tolerance to lymphocytic choriomeningitis virus in neonatally infected virus carrier mice: evidence supporting a clonal inactivation mechanism. Immunology. 1978 Feb;34(2):265–275. [PMC free article] [PubMed] [Google Scholar]
  17. Clements J. E., Pedersen F. S., Narayan O., Haseltine W. A. Genomic changes associated with antigenic variation of visna virus durig persistent infection. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4454–4458. doi: 10.1073/pnas.77.8.4454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Cohen P. L., Cross S. S., Mosier D. E. Immunologic effects of neonatal infection with mouse thymic virus. J Immunol. 1975 Sep;115(3):706–710. [PubMed] [Google Scholar]
  19. Colonna Romano G., Dieli F., Abrignani S., Salerno A., Colizzi V. Inhibition of lymphocyte mitogenesis in mice infected with Newcastle disease virus: viral interference with the interleukin system. Immunology. 1986 Mar;57(3):373–378. [PMC free article] [PubMed] [Google Scholar]
  20. Coutelier J. P., Van Snick J. Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus. Eur J Immunol. 1985 Mar;15(3):250–255. doi: 10.1002/eji.1830150308. [DOI] [PubMed] [Google Scholar]
  21. Cremer N. E., Devlin V. L., Riggs J. L., Hagens S. J. Anomalous antibody responses in viral infection: specific stimulation or polyclonal activation? J Clin Microbiol. 1984 Sep;20(3):468–472. doi: 10.1128/jcm.20.3.468-472.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Dales S., Fujinami R. S., Oldstone M. B. Infection with vaccinia favors the selection of hybridomas synthesizing autoantibodies against intermediate filaments, one of them cross-reacting with the virus hemagglutinin. J Immunol. 1983 Sep;131(3):1546–1553. [PubMed] [Google Scholar]
  23. Dalgleish A. G., Beverley P. C., Clapham P. R., Crawford D. H., Greaves M. F., Weiss R. A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984 Dec 20;312(5996):763–767. doi: 10.1038/312763a0. [DOI] [PubMed] [Google Scholar]
  24. Diener E., Feldmann M. Mechanisms at the cellular level during induction of high zone tolerance in vitro. Cell Immunol. 1972 Sep;5(1):130–136. doi: 10.1016/0008-8749(72)90090-1. [DOI] [PubMed] [Google Scholar]
  25. Einhorn L., Ost A. Cytomegalovirus infection of human blood cells. J Infect Dis. 1984 Feb;149(2):207–214. doi: 10.1093/infdis/149.2.207. [DOI] [PubMed] [Google Scholar]
  26. Feldmann M. Lymphokines and interleukins emerge from the primeval soup. 1985 Jan 31-Feb 6Nature. 313(6001):351–352. doi: 10.1038/313351a0. [DOI] [PubMed] [Google Scholar]
  27. Fuccillo D. A., Steele R. W., Hensen S. A., Vincent M. M., Hardy J. B., Bellanti J. A. Impaired cellular immunity to rubella virus in congenital rubella. Infect Immun. 1974 Jan;9(1):81–84. doi: 10.1128/iai.9.1.81-84.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Fujinami R. S., Oldstone M. B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 1985 Nov 29;230(4729):1043–1045. doi: 10.1126/science.2414848. [DOI] [PubMed] [Google Scholar]
  29. Fujinami R. S., Oldstone M. B., Wroblewska Z., Frankel M. E., Koprowski H. Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci U S A. 1983 Apr;80(8):2346–2350. doi: 10.1073/pnas.80.8.2346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Gardiner A. C., Nettleton P. F., Barlow R. M. Virology and immunology of a spontaneous and experimental mucosal disease-like syndrome in sheep recovered from clinical border disease. J Comp Pathol. 1983 Jul;93(3):463–469. doi: 10.1016/0021-9975(83)90033-6. [DOI] [PubMed] [Google Scholar]
  31. Garzelli C., Onodera T., Ray U. R., Notkins A. L. The S1 gene from reovirus type 1 is required for immunosuppression. J Infect Dis. 1985 Sep;152(3):640–643. doi: 10.1093/infdis/152.3.640. [DOI] [PubMed] [Google Scholar]
  32. Garzelli C., Taub F. E., Scharff J. E., Prabhakar B. S., Ginsberg-Fellner F., Notkins A. L. Epstein-Barr virus-transformed lymphocytes produce monoclonal autoantibodies that react with antigens in multiple organs. J Virol. 1984 Nov;52(2):722–725. doi: 10.1128/jvi.52.2.722-725.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Gendelman H. E., Narayan O., Kennedy-Stoskopf S., Kennedy P. G., Ghotbi Z., Clements J. E., Stanley J., Pezeshkpour G. Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol. 1986 Apr;58(1):67–74. doi: 10.1128/jvi.58.1.67-74.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Gilden D. H., Cole G. A., Monjan A. A., Nathanson N. Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice. J Exp Med. 1972 Apr 1;135(4):860–873. doi: 10.1084/jem.135.4.860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Gillis S., Crabtree G. R., Smith K. A. Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol. 1979 Oct;123(4):1624–1631. [PubMed] [Google Scholar]
  36. Goodman-Snitkoff G., Mannino R. J., McSharry J. J. The glycoprotein isolated from vesicular stomatitis virus is mitogenic for mouse B lymphocytes. J Exp Med. 1981 Jun 1;153(6):1489–1502. doi: 10.1084/jem.153.6.1489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Goswami K. K., Morris R. J., Rastogi S. C., Lange L. S., Russell W. C. A neutralising monoclonal antibody against a paramyxovirus reacts with a brain antigen. J Neuroimmunol. 1985 Jul;9(1-2):99–108. doi: 10.1016/s0165-5728(85)80010-2. [DOI] [PubMed] [Google Scholar]
  38. Greene M. I., Weiner H. L. Delayed hypersensitivity in mice infected with reovirus. II. Induction of tolerance and suppressor T cells to viral specific gene products. J Immunol. 1980 Jul;125(1):283–287. [PubMed] [Google Scholar]
  39. Halstead S. B. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis. 1979 Oct;140(4):527–533. doi: 10.1093/infdis/140.4.527. [DOI] [PubMed] [Google Scholar]
  40. Hardt C., Röllinghoff M., Pfizenmaier K., Mosmann H., Wagner H. Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo. J Exp Med. 1981 Aug 1;154(2):262–274. doi: 10.1084/jem.154.2.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Hayward A. R., Herberger M. J., Groothuis J., Levin M. R. Specific immunity after congenital or neonatal infection with cytomegalovirus or herpes simplex virus. J Immunol. 1984 Nov;133(5):2469–2473. [PubMed] [Google Scholar]
  42. Helenius A., Morein B., Fries E., Simons K., Robinson P., Schirrmacher V., Terhorst C., Strominger J. L. Human (HLA-A and HLA-B) and murine (H-2K and H-2D) histocompatibility antigens are cell surface receptors for Semliki Forest virus. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3846–3850. doi: 10.1073/pnas.75.8.3846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Hess W. R. African swine fever: a reassessment. Adv Vet Sci Comp Med. 1981;25:39–69. [PubMed] [Google Scholar]
  44. Hooton J. W., Riendeau D., Paetkau V. Is IL-2 regulated by a serum inhibitor? Cell Immunol. 1985 Oct 15;95(2):311–321. doi: 10.1016/0008-8749(85)90318-1. [DOI] [PubMed] [Google Scholar]
  45. Horohov D. W., Moore R. N., Rouse B. T. Regulation of herpes simplex virus-specific lymphoproliferation by suppressor cells. J Virol. 1985 Oct;56(1):1–6. doi: 10.1128/jvi.56.1.1-6.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Horohov D. W., Wyckoff J. H., 3rd, Moore R. N., Rouse B. T. Regulation of herpes simplex virus-specific cell-mediated immunity by a specific suppressor factor. J Virol. 1986 May;58(2):331–338. doi: 10.1128/jvi.58.2.331-338.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Hutt-Fletcher L. M., Balachandran N., Elkins M. H. B cell activation by cytomegalovirus. J Exp Med. 1983 Dec 1;158(6):2171–2176. doi: 10.1084/jem.158.6.2171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Hyypiä T., Korkiamäki P., Vainionpä R. Replication of measles virus in human lymphocytes. J Exp Med. 1985 Jun 1;161(6):1261–1271. doi: 10.1084/jem.161.6.1261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Inada T., Chong K. T., Mims C. A. Enhancing antibodies, macrophages and virulence in mouse cytomegalovirus infection. J Gen Virol. 1985 Apr;66(Pt 4):871–878. doi: 10.1099/0022-1317-66-4-871. [DOI] [PubMed] [Google Scholar]
  50. Inada T., Mims C. A. Infection of mice with lactic dehydrogenase virus prevents development of experimental allergic encephalomyelitis. J Neuroimmunol. 1986 Mar;11(1):53–56. doi: 10.1016/0165-5728(86)90074-3. [DOI] [PubMed] [Google Scholar]
  51. Inada T., Mims C. A. Pattern of infection and selective loss of Ia positive cells in suckling and adult mice inoculated with lactic dehydrogenase virus. Arch Virol. 1985;86(3-4):151–165. doi: 10.1007/BF01309821. [DOI] [PubMed] [Google Scholar]
  52. Isakov N., Feldman M., Segal S. Acute infection of mice with lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of their macrophages. Cell Immunol. 1982 Jan 15;66(2):317–332. doi: 10.1016/0008-8749(82)90182-4. [DOI] [PubMed] [Google Scholar]
  53. Jahnke U., Fischer E. H., Alvord E. C., Jr Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science. 1985 Jul 19;229(4710):282–284. doi: 10.1126/science.2409602. [DOI] [PubMed] [Google Scholar]
  54. Jakab G. J., Dick E. C. Synergistic effect in viral-bacterial infection: combined infection of the murine respiratory tract with Sendai virus and Pasteurella pneumotropica. Infect Immun. 1973 Nov;8(5):762–768. doi: 10.1128/iai.8.5.762-768.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Janossy G., Pinching A. J., Bofill M., Weber J., McLaughlin J. E., Ornstein M., Ivory K., Harris J. R., Favrot M., Macdonald-Burns D. C. An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS. Clin Exp Immunol. 1985 Feb;59(2):257–266. [PMC free article] [PubMed] [Google Scholar]
  56. Jennings S. R., Rice P. L., Kloszewski E. D., Anderson R. W., Thompson D. L., Tevethia S. S. Effect of herpes simplex virus types 1 and 2 on surface expression of class I major histocompatibility complex antigens on infected cells. J Virol. 1985 Dec;56(3):757–766. doi: 10.1128/jvi.56.3.757-766.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Kanki P. J., Alroy J., Essex M. Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys. Science. 1985 Nov 22;230(4728):951–954. doi: 10.1126/science.2997923. [DOI] [PubMed] [Google Scholar]
  58. Kennedy P. G., Narayan O., Ghotbi Z., Hopkins J., Gendelman H. E., Clements J. E. Persistent expression of Ia antigen and viral genome in visna-maedi virus-induced inflammatory cells. Possible role of lentivirus-induced interferon. J Exp Med. 1985 Dec 1;162(6):1970–1982. doi: 10.1084/jem.162.6.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Kizaka S., Goodman-Snitkoff G., McSharry J. J. Sendai virus glycoproteins are T cell-dependent B cell mitogens. Infect Immun. 1983 May;40(2):592–600. doi: 10.1128/iai.40.2.592-600.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Kono Y., Kobayashi K., Fukunaga Y. Antigenic drift of equine infectious anemia virus in chronically infected horses. Arch Gesamte Virusforsch. 1973;41(1):1–10. doi: 10.1007/BF01249923. [DOI] [PubMed] [Google Scholar]
  61. Kärre K., Ljunggren H. G., Piontek G., Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 1986 Feb 20;319(6055):675–678. doi: 10.1038/319675a0. [DOI] [PubMed] [Google Scholar]
  62. Käufer I., Weiss E. Significance of bursa of Fabricius as target organ in infectious bursal disease of chickens. Infect Immun. 1980 Feb;27(2):364–367. doi: 10.1128/iai.27.2.364-367.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Lamb J. R., Feldmann M. Essential requirement for major histocompatibility complex recognition in T-cell tolerance induction. Nature. 1984 Mar 1;308(5954):72–74. doi: 10.1038/308072a0. [DOI] [PubMed] [Google Scholar]
  64. Lamb J. R., Skidmore B. J., Green N., Chiller J. M., Feldmann M. Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med. 1983 May 1;157(5):1434–1447. doi: 10.1084/jem.157.5.1434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Lane H. C., Depper J. M., Greene W. C., Whalen G., Waldmann T. A., Fauci A. S. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med. 1985 Jul 11;313(2):79–84. doi: 10.1056/NEJM198507113130204. [DOI] [PubMed] [Google Scholar]
  66. Lane H. C., Masur H., Edgar L. C., Whalen G., Rook A. H., Fauci A. S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983 Aug 25;309(8):453–458. doi: 10.1056/NEJM198308253090803. [DOI] [PubMed] [Google Scholar]
  67. Lelchuk R., Playfair J. H. Serum IL-2 inhibitor in mice. I. Increase during infection. Immunology. 1985 Sep;56(1):113–118. [PMC free article] [PubMed] [Google Scholar]
  68. Leung K., Ashman R. B., Ertl H. C., Ada G. L. Selective suppression of the cytotoxic T cell response to influenza virus in mice. Eur J Immunol. 1980 Nov;10(11):803–810. doi: 10.1002/eji.1830101102. [DOI] [PubMed] [Google Scholar]
  69. Liao Z., Grimshaw R. S., Rosenstreich D. L. Identification of a specific interleukin 1 inhibitor in the urine of febrile patients. J Exp Med. 1984 Jan 1;159(1):126–136. doi: 10.1084/jem.159.1.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Liew F. Y. Regulation of delayed-type hypersensitivity. I. T suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice. Eur J Immunol. 1977 Oct;7(10):714–718. doi: 10.1002/eji.1830071013. [DOI] [PubMed] [Google Scholar]
  71. Liew F. Y., Russell S. M. Delayed-type hypersensitivity to influenza virus. Induction of antigen-specific suppressor T cells for delayed-type hypersensitivity to hemagglutinin during influenza virus infection in mice. J Exp Med. 1980 Apr 1;151(4):799–814. doi: 10.1084/jem.151.4.799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Loh L., Hudson J. B. Murine cytomegalovirus-induced immunosuppression. Infect Immun. 1982 Apr;36(1):89–95. doi: 10.1128/iai.36.1.89-95.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Male D., Lelchuk R., Curry S., Pryce G., Playfair J. H. Serum IL-2 inhibitor in mice. II. Molecular characteristics. Immunology. 1985 Sep;56(1):119–125. [PMC free article] [PubMed] [Google Scholar]
  74. Marker O., Volkert M. Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice. J Exp Med. 1973 Jun 1;137(6):1511–1525. doi: 10.1084/jem.137.6.1511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Mathes L. E., Olsen R. G., Hebebrand L. C., Hoover E. A., Schaller J. P., Adams P. W., Nichols W. S. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus. Cancer Res. 1979 Mar;39(3):950–955. [PubMed] [Google Scholar]
  76. McDougal J. S., Kennedy M. S., Sligh J. M., Cort S. P., Mawle A., Nicholson J. K. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science. 1986 Jan 24;231(4736):382–385. doi: 10.1126/science.3001934. [DOI] [PubMed] [Google Scholar]
  77. Mellow G. H., Föhring B., Dougherty J., Gallimore P. H., Raska K., Jr Tumorigenicity of adenovirus-transformed rat cells and expression of class I major histocompatibility antigen. Virology. 1984 Apr 30;134(2):460–465. doi: 10.1016/0042-6822(84)90313-1. [DOI] [PubMed] [Google Scholar]
  78. Michaelides M. C., Simms E. S. Immune responses in mice infected with lactic dehydrogenase virus. III. Antibody response to a T-dependent and a T-independent antigen during acute and chronic LDV infection. Cell Immunol. 1980 Mar 15;50(2):253–260. doi: 10.1016/0008-8749(80)90280-4. [DOI] [PubMed] [Google Scholar]
  79. Mims C. A., Wainwright S. The immunodepressive action of lymphocytic choriomeningitis virus in mice. J Immunol. 1968 Oct;101(4):717–724. [PubMed] [Google Scholar]
  80. Mitsuya H., Guo H. G., Cossman J., Megson M., Reitz M. S., Jr, Broder S. Functional properties of antigen-specific T cells infected by human T-cell leukemia-lymphoma virus (HTLV-I). Science. 1984 Sep 28;225(4669):1484–1486. doi: 10.1126/science.6206569. [DOI] [PubMed] [Google Scholar]
  81. Morahan P. S., Connor J. R., Leary K. R. Viruses and the versatile macrophage. Br Med Bull. 1985 Jan;41(1):15–21. doi: 10.1093/oxfordjournals.bmb.a072017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Morichika S., Hada H., Arima T., Togawa K., Watanabe M., Nagashima H. Hepatitis B virus DNA replication in peripheral blood mononuclear cells. Lancet. 1985 Dec 21;2(8469-70):1431–1431. doi: 10.1016/s0140-6736(85)92600-5. [DOI] [PubMed] [Google Scholar]
  83. Morishima T., McClintock P. R., Billups L. C., Notkins A. L. Expression and modulation of virus receptors on lymphoid and myeloid cells: relationship to infectivity. Virology. 1982 Jan 30;116(2):605–618. doi: 10.1016/0042-6822(82)90152-0. [DOI] [PubMed] [Google Scholar]
  84. Morse H. C., 3rd, Cross S. S., Baker P. J. Neonatal infection with mouse thymic virus: effects on cells regulating the antibody response to type III pneumococcal polysaccharide. J Immunol. 1976 Jun;116(6):1613–1617. [PubMed] [Google Scholar]
  85. Muchmore A. V., Decker J. M. Uromodulin: a unique 85-kilodalton immunosuppressive glycoprotein isolated from urine of pregnant women. Science. 1985 Aug 2;229(4712):479–481. doi: 10.1126/science.2409603. [DOI] [PubMed] [Google Scholar]
  86. Müller H. Replication of infectious bursal disease virus in lymphoid cells. Arch Virol. 1986;87(3-4):191–203. doi: 10.1007/BF01315299. [DOI] [PubMed] [Google Scholar]
  87. Narayan O., Kennedy-Stoskopf S., Sheffer D., Griffin D. E., Clements J. E. Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect Immun. 1983 Jul;41(1):67–73. doi: 10.1128/iai.41.1.67-73.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Narayan O., Sheffer D., Griffin D. E., Clements J., Hess J. Lack of neutralizing antibodies to caprine arthritis-encephalitis lentivirus in persistently infected goats can be overcome by immunization with inactivated Mycobacterium tuberculosis. J Virol. 1984 Feb;49(2):349–355. doi: 10.1128/jvi.49.2.349-355.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Nash A. A., Phelan J., Gell P. G., Wildy P. Tolerance and immunity in mice infected with herpes simplex virus: studies on the mechanism of tolerance to delayed-type hypersensitivity. Immunology. 1981 Jun;43(2):363–369. [PMC free article] [PubMed] [Google Scholar]
  90. Nepom J. T., Weiner H. L., Dichter M. A., Tardieu M., Spriggs D. R., Gramm C. F., Powers M. L., Fields B. N., Greene M. I. Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cells. J Exp Med. 1982 Jan 1;155(1):155–167. doi: 10.1084/jem.155.1.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Noseworthy J. H., Fields B. N., Dichter M. A., Sobotka C., Pizer E., Perry L. L., Nepom J. T., Greene M. I. Cell receptors for the mammalian reovirus. I. Syngeneic monoclonal anti-idiotypic antibody identifies a cell surface receptor for reovirus. J Immunol. 1983 Nov;131(5):2533–2538. [PubMed] [Google Scholar]
  92. Notkins A. L., Mage M., Ashe W. K., Mahar S. Neutralization of sensitized lactic dehydrogenase virus by anti-gammglobulin. J Immunol. 1968 Feb;100(2):314–320. [PubMed] [Google Scholar]
  93. Notkins A. L., Mergenhagen S. E., Howard R. J. Effect of virus infections on the function of the immune system. Annu Rev Microbiol. 1970;24:525–538. doi: 10.1146/annurev.mi.24.100170.002521. [DOI] [PubMed] [Google Scholar]
  94. Notkins A. L., Mergenhagen S. E., Rizzo A. A., Scheele C., Waldmann T. A. Elevated gamma-globulin and increased antibody production in mice infected with lactic dehydrogenase virus. J Exp Med. 1966 Feb 1;123(2):347–364. doi: 10.1084/jem.123.2.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Oldstone M. B., Dixon F. J. Inhibition of antibodies to nuclear antigen and to DNA in New Zealand mice infected with lactate dehydrogenase virus. Science. 1972 Feb 18;175(4023):784–786. doi: 10.1126/science.175.4023.784. [DOI] [PubMed] [Google Scholar]
  96. Oldstone M. B., Dixon F. J. Lymphocytic choriomeningitis: production of antibody by "tolerant" infected mice. Science. 1967 Dec 1;158(3805):1193–1195. doi: 10.1126/science.158.3805.1193. [DOI] [PubMed] [Google Scholar]
  97. Oldstone M. B., Tishon A., Dutko F. J., Kennedy S. I., Holland J. J., Lampert P. W. Does the major histocompatibility complex serve as a specific receptor for Semliki Forest virus? J Virol. 1980 Apr;34(1):256–265. doi: 10.1128/jvi.34.1.256-265.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Orosz C. G., Zinn N. E., Olsen R. G., Mathes L. E. Retrovirus-mediated immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion. J Immunol. 1985 Jul;135(1):583–590. [PubMed] [Google Scholar]
  99. Pahwa S., Pahwa R., Saxinger C., Gallo R. C., Good R. A. Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8198–8202. doi: 10.1073/pnas.82.23.8198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Payne S., Parekh B., Montelaro R. C., Issel C. J. Genomic alterations associated with persistent infections by equine infectious anaemia virus, a retrovirus. J Gen Virol. 1984 Aug;65(Pt 8):1395–1399. doi: 10.1099/0022-1317-65-8-1395. [DOI] [PubMed] [Google Scholar]
  101. Pelton B. K., Imrie R. C., Denman A. M. Susceptibility of human lymphocyte populations to infection by herpes simplex virus. Immunology. 1977 May;32(5):803–810. [PMC free article] [PubMed] [Google Scholar]
  102. Perryman L. E., Hoover E. A., Yohn D. S. Immunologic reactivity of the cat: immunosuppression in experimental feline leukemia. J Natl Cancer Inst. 1972 Nov;49(5):1357–1365. [PubMed] [Google Scholar]
  103. Pesanti E. L., Shanley J. D. Murine cytomegalovirus-induced macrophage dysfunction. J Leukoc Biol. 1984 Aug;36(2):133–141. doi: 10.1002/jlb.36.2.133. [DOI] [PubMed] [Google Scholar]
  104. Pontisso P., Poon M. C., Tiollais P., Brechot C. Detection of hepatitis B virus DNA in mononuclear blood cells. Br Med J (Clin Res Ed) 1984 May 26;288(6430):1563–1566. doi: 10.1136/bmj.288.6430.1563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Popovic M., Flomenberg N., Volkman D. J., Mann D., Fauci A. S., Dupont B., Gallo R. C. Alteration of T-cell functions by infection with HTLV-I or HTLV-II. Science. 1984 Oct 26;226(4673):459–462. doi: 10.1126/science.6093248. [DOI] [PubMed] [Google Scholar]
  106. Porter D. D., Larsen A. E., Porter H. G. Aleutian disease of mink. Adv Immunol. 1980;29:261–286. doi: 10.1016/s0065-2776(08)60046-2. [DOI] [PubMed] [Google Scholar]
  107. Porter D. D., Larsen A. E., Porter H. G. The pathogenesis of Aleutian disease of mink. I. In vivo viral replication and the host antibody response to viral antigen. J Exp Med. 1969 Sep 1;130(3):575–593. doi: 10.1084/jem.130.3.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Prabhakar B. S., Saegusa J., Onodera T., Notkins A. L. Lymphocytes capable of making monoclonal autoantibodies that react with multiple organs are a common feature of the normal B cell repertoire. J Immunol. 1984 Dec;133(6):2815–2817. [PubMed] [Google Scholar]
  109. Päbo S., Kämpe O., Severinsson L., Andersson M., Fernandez C., Peterson P. A. The association between class-I transplantation antigens and an adenovirus membrane protein. Prog Allergy. 1985;36:114–134. [PubMed] [Google Scholar]
  110. ROWE W. P., CAPPS W. I. A new mouse virus causing necrosis of the thymus in newborn mice. J Exp Med. 1961 May 1;113:831–844. doi: 10.1084/jem.113.5.831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Rajewsky K., Brenig C. Paralysis to serum albumins in T and B lymphocytes in mice. Dose dependence, specificity and kinetics of escape. Eur J Immunol. 1974 Feb;4(2):120–125. doi: 10.1002/eji.1830040211. [DOI] [PubMed] [Google Scholar]
  112. Rice G. P., Schrier R. D., Oldstone M. B. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc Natl Acad Sci U S A. 1984 Oct;81(19):6134–6138. doi: 10.1073/pnas.81.19.6134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Roberts N. J., Jr, Prill A. H., Mann T. N. Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor activity. J Exp Med. 1986 Mar 1;163(3):511–519. doi: 10.1084/jem.163.3.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Rodgers B. C., Scott D. M., Mundin J., Sissons J. G. Monocyte-derived inhibitor of interleukin 1 induced by human cytomegalovirus. J Virol. 1985 Sep;55(3):527–532. doi: 10.1128/jvi.55.3.527-532.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Romet-Lemonne J. L., McLane M. F., Elfassi E., Haseltine W. A., Azocar J., Essex M. Hepatitis B virus infection in cultured human lymphoblastoid cells. Science. 1983 Aug 12;221(4611):667–669. doi: 10.1126/science.6867736. [DOI] [PubMed] [Google Scholar]
  116. Rowson K. E., Mahy B. W. Lactate dehydrogenase-elevating virus. J Gen Virol. 1985 Nov;66(Pt 11):2297–2312. doi: 10.1099/0022-1317-66-11-2297. [DOI] [PubMed] [Google Scholar]
  117. Scott J. V., Stowring L., Haase A. T., Narayan O., Vigne R. Antigenic variation in visna virus. Cell. 1979 Oct;18(2):321–327. doi: 10.1016/0092-8674(79)90051-5. [DOI] [PubMed] [Google Scholar]
  118. Stern H., Hannington G., Booth J., Moncrieff D. An early marker of fetal infection after primary cytomegalovirus infection in pregnancy. Br Med J (Clin Res Ed) 1986 Mar 15;292(6522):718–720. doi: 10.1136/bmj.292.6522.718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Symington J., McCann A. K., Schlesinger M. J. Infectious virus-antibody complexes of sindbis virus. Infect Immun. 1977 Mar;15(3):720–725. doi: 10.1128/iai.15.3.720-725.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Tanaka K., Isselbacher K. J., Khoury G., Jay G. Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene. Science. 1985 Apr 5;228(4695):26–30. doi: 10.1126/science.3975631. [DOI] [PubMed] [Google Scholar]
  121. Tardieu M., Powers M. L., Hafler D. A., Hauser S. L., Weiner H. L. Autoimmunity following viral infection: demonstration of monoclonal antibodies against normal tissue following infection of mice with reovirus and demonstration of shared antigenicity between virus and lymphocytes. Eur J Immunol. 1984 Jun;14(6):561–565. doi: 10.1002/eji.1830140614. [DOI] [PubMed] [Google Scholar]
  122. Tattersall P., Bratton J. Reciprocal productive and restrictive virus-cell interactions of immunosuppressive and prototype strains of minute virus of mice. J Virol. 1983 Jun;46(3):944–955. doi: 10.1128/jvi.46.3.944-955.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Tenner-Racz K., Racz P., Bofill M., Schulz-Meyer A., Dietrich M., Kern P., Weber J., Pinching A. J., Veronese-Dimarzo F., Popovic M. HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. Am J Pathol. 1986 Apr;123(1):9–15. [PMC free article] [PubMed] [Google Scholar]
  124. Trainin Z., Wernicke D., Ungar-Waron H., Essex M. Suppression of the humoral antibody response in natural retrovirus infections. Science. 1983 May 20;220(4599):858–859. doi: 10.1126/science.6302837. [DOI] [PubMed] [Google Scholar]
  125. Verder H., Dickmeiss E., Haahr S., Kappelgaard E., Leerbøy J., Møller-Larsen A., Nielsen H., Platz P., Koch C. Late-onset rubella syndrome: coexistence of immune complex disease and defective cytotoxic effector cell function. Clin Exp Immunol. 1986 Feb;63(2):367–375. [PMC free article] [PubMed] [Google Scholar]
  126. Wainberg M. A., Portnoy J. D., Clecner B., Hubschman S., Lagacé-Simard J., Rabinovitch N., Remer Z., Mendelson J. Viral inhibition of lymphocyte proliferative responsiveness in patients suffering from recurrent lesions caused by herpes simplex virus. J Infect Dis. 1985 Sep;152(3):441–448. doi: 10.1093/infdis/152.3.441. [DOI] [PubMed] [Google Scholar]
  127. Wainberg M. A., Vydelingum S., Boushira M., Legacé-Simard J., Margolese R. G., Spira B., Mendelson J. Reversible interference with TCGF activity by virus particles. Clin Exp Immunol. 1984 Sep;57(3):663–670. [PMC free article] [PubMed] [Google Scholar]
  128. Wainberg M. A., Vydelingum S., Margolese R. G. Viral inhibition of lymphocyte mitogenesis: interference with the synthesis of functionally active T cell growth factor (TCGF) activity and reversal of inhibition by the addition of same. J Immunol. 1983 May;130(5):2372–2378. [PubMed] [Google Scholar]
  129. Wallnerova Z., Mims C. A. Thoracic lymph duct cannulation of mice infected with lymphocytic choriomeningitis (LCM) and ectromelia viruses. Arch Gesamte Virusforsch. 1971;35(2):152–160. doi: 10.1007/BF01249706. [DOI] [PubMed] [Google Scholar]
  130. Wardley R. C., de M Andrade C., Black D. N., de Castro Portugal F. L., Enjuanes L., Hess W. R., Mebus C., Ordas A., Rutili D., Sanchez Vizcaino J. African Swine Fever virus. Brief review. Arch Virol. 1983;76(2):73–90. doi: 10.1007/BF01311692. [DOI] [PubMed] [Google Scholar]
  131. Weiss R. A., Clapham P. R., Cheingsong-Popov R., Dalgleish A. G., Carne C. A., Weller I. V., Tedder R. S. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature. 1985 Jul 4;316(6023):69–72. doi: 10.1038/316069a0. [DOI] [PubMed] [Google Scholar]
  132. Weiss R. C., Scott F. W. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp Immunol Microbiol Infect Dis. 1981;4(2):175–189. doi: 10.1016/0147-9571(81)90003-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES